Hypersensitivity reactions to paclitaxel and carboplatin in breast cancer: safety and effectiveness of desensitization

被引：0
|
作者：
Villarreal-Gonzalez, Rosalaura V.
Vidal-Gutierrez, Oscar
Martinez-Moyano, Javier A.
Madrazo-Morales, Marianela
Saenz-Cantu, Kathia S.
Rodriguez-Nino, Patricia
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO3-12-08
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO3-12-08
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Carboplatin hypersensitivity reactions (HSR) in carboplatin retreatment for recurrent ovarian cancer.
    O'Cearbhaill, Roisin Eilish
    Hyman, David Michael
    Tew, William P.
    Iasonos, Alexia
    Cangemi, Nicholas A.
    Aghajanian, Carol
    Bell-McGuinn, Katherine M.
    Makker, Vicky
    Hensley, Martee Leigh
    Konner, Jason A.
    Grisham, Rachel N.
    Diaz-Macinnis, Katherine
    Sabbatini, Paul
    Spriggs, David R.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [32] Impact of carboplatin hypersensitivity and desensitization on overall survival in patients with recurrent ovarian cancer
    Altwerger, G.
    Han, C.
    Zeybek, B.
    Haines, K.
    Gressel, G. M.
    Huang, G. S.
    Litkouhi, B.
    Azodi, M.
    Silasi, D. A.
    Santin, A. D.
    Schwartz, P. E.
    Ratner, E. S.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 28 - 29
  • [33] DESENSITIZATION PROTOCOL FOR HYPERSENSITIVITY TO CARBOPLATIN INPATIENT WITH METASTATIC CANCER, A SAFE AND EFFECTIVE METHOD
    Ramirez Rodriquez, R.
    Gonzalez-Diaz, S.
    Macias-Weinmann, A.
    Arias-Cruz, A.
    Villarreal Gonzalez, R.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S72 - S73
  • [34] PACLITAXEL PLUS CARBOPLATIN FOR WOMEN WITH ADVANCED BREAST CANCER
    Ju Liu
    ChineseMedicalSciencesJournal, 2007, (02) : 93 - 97
  • [35] DESENSITIZATION TO DELAYED HYPERSENSITIVITY REACTIONS
    SCHLOSSM.SF
    LEVINE, H
    FEDERATION PROCEEDINGS, 1967, 26 (02) : 477 - &
  • [36] FEASIBILITY OF AN OUTPATIENT 12-STEP DESENSITIZATION FOR PATIENTS WITH HISTORY OF CARBOPLATIN HYPERSENSITIVITY REACTIONS (HSR) UNDERGOING RETREATMENT WITH CARBOPLATIN FOR RECURRENT OVARIAN OR ENDOMETRIAL CANCER
    LaVigne, K.
    Eroglu, I.
    Mainardi, T.
    Sabbatini, P.
    Sklarin, N.
    O'Cearbhaill, R.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A131 - A132
  • [37] Hypersensitivity Reactions to Taxanes: A Comprehensive and Systematic Review of the Efficacy and Safety of Desensitization
    Rosalaura Virginia Villarreal-González
    Sandra González-Díaz
    Oscar Vidal-Gutiérrez
    Alejandra Canel-Paredes
    Carlos de la Cruz-de la Cruz
    Mariano García-Campa
    Alfonso López-Méndez
    Sofía Alvarado-Ruiz
    Mariana Castells
    Clinical Reviews in Allergy & Immunology, 2023, 65 : 231 - 250
  • [38] Hypersensitivity Reactions to Taxanes: A Comprehensive and Systematic Review of the Efficacy and Safety of Desensitization
    Villarreal-Gonzalez, Rosalaura Virginia
    Gonzalez-Diaz, Sandra
    Vidal-Gutierrez, Oscar
    Canel-Paredes, Alejandra
    de la de la Cruz, Carlos
    Garcia-Campa, Mariano
    Lopez-Mendez, Alfonso
    Alvarado-Ruiz, Sofia
    Castells, Mariana
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2023, 65 (02) : 231 - 250
  • [39] Hypersensitivity reactions to chemotherapy: Outcomes and safety of rapid desensitization in 413 cases
    Castells, Mariana C.
    Tennant, Nichole M.
    Sloane, David E.
    Hsu, F. Ida
    Barrett, Nora A.
    Hong, David I.
    Laidlaw, Tanya M.
    Legere, Henry J.
    Nallamshetty, Samridhi N.
    Palis, Ross I.
    Rao, Jayanti J.
    Berlin, Suzanne T.
    Campos, Susana M.
    Matulonis, Ursula A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 122 (03) : 574 - 580
  • [40] Hypersensitivity reactions to anticancer chemotherapy and monoclonal antibodies: Safety and efficacy of desensitization
    Villarreal-Gonzalez, Rosalaura V.
    Gonzalez-Diaz, Sandra
    Vidal-Gutierrez, Oscar
    de la Cruz, Carlos de la Cruz
    Perez-Ibave, Diana C.
    Garza-Rodriguez, Maria L.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024, 30 (05) : 811 - 822
12345